: GoodRx stock surges 15% after earnings beat


GoodRx Holdings Inc. GDRX, +1.54% shares surged in the extended session Tuesday after the consumer-targeted digital healthcare platform topped expectations for the quarter. GoodRx shares rallied as much as 15% after hours, following a 1.5% rise in the regular session to close at $5.29. The company reported a fourth-quarter loss of $2 million, or break-even a share, compared with a loss of $39.9 million, or 10 cents a share, in the year-ago period. The adjusted loss, which excludes stock-based compensation expenses and other items, was 7 cents a share, even with the year-ago period. Revenue declined to $184.1 million from $213.3 million in the year-ago quarter. Analysts surveyed by FactSet had forecast an adjusted profit of 5 cents a share on revenue of $178.5 million. GoodRx forecast revenue between $181 million to $183 million for the first quarter, and revenue of $780 million to $790 million for the year.

This article was originally published by Marketwatch.com. Read the original article here.

Previous article: FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
Next articleFDA advisers recommend Pfizer’s RSV vaccine for older adults


Please enter your comment!
Please enter your name here